Cryptocurrency
Bitcoin tops $71K as Trump signals ceasefire
Bitcoin climbed to approximately $71,500 on April 7 after US President Donald Trump announced a two-week pause on planned military strikes against Iran, signalling potential de-escalation.
Brie Carter
TV Presenter & Finance EditorTV presenter and finance editor at Grafa, with a Master’s in Commerce from UWA and diverse industry experience in finance, insurance, and media.
Contact
Contact editorial teamArticles by Brie Carter
Albanese fast-tracks Singapore trip over fuel crisis
PM Albanese fast-tracks Singapore summit to secure Australia's fuel supply amid a global energy crisis and rising diesel shortages.
5G Networks appoints Nathan Legg as CFO
5G Networks (ASX:5GN) announced the immediate resignation of CFO Kieran Donavan.
Ben Roberts-Smith to face five murder charges
The Australian Federal Police expects to charge Victoria Cross recipient Ben Roberts-Smith with five counts of murder over alleged war crimes in Afghanistan.
Consumer staples
a2 Milk settles shareholder class action for $62M
a2 Milk (ASX:A2M) has settled a long-standing shareholder class action for $62 million.
Lexaria Bioscience welcomes FDA approval of Eli Lilly’s Foundayo as oral GLP-1 market expands
Lexaria Bioscience (NASDAQ:LEXX), a global innovator in drug delivery platforms, issued a statement on April 7, 2026, applauding the U.S. Food and Drug Administration (FDA) approval of Eli Lilly’s Foundayo, the latest oral GLP-1 receptor agonist for chronic weight management in adults.
FDA grants Outlook Therapeutics formal dispute resolution meeting for ONS-5010
Outlook Therapeutics (NASDAQ:OTLK), a biopharmaceutical company working to develop the first FDA-approved ophthalmic formulation of bevacizumab, announced on April 7, 2026, that the U.S. Food and Drug Administration (FDA) has accepted its Formal Dispute Resolution Request (FDRR) regarding ONS-5010/LYTENAVA™ (bevacizumab-vikg).
Technology
ASML shares fall as U.S. lawmakers propose further curbs on China exports
Shares of ASML Holding (NYSE:ASML) declined on Tuesday as investors reacted to a new legislative proposal from U.S. lawmakers that could significantly tighten restrictions on the company’s ability to sell and service advanced chipmaking equipment in China.
Soleno Therapeutics withdraws European marketing application for VYKAT XR
Soleno Therapeutics (NASDAQ:SLNO), a clinical-stage biopharmaceutical company developing novel treatments for rare diseases, announced on April 7, 2026, that it has voluntarily withdrawn its Marketing Authorization Application (MAA) from the European Medicines Agency (EMA) for VIOKAT prolonged-release tablets.
Lifezone Metals achieves first PGM production from recycled catalytic converters
Lifezone Metals (NYSE:LZM) has announced the first successful production of platinum, palladium, and rhodium from U.S.-sourced spent automotive catalytic converters, marking a technical milestone for its proprietary Hydromet Technology.